Dr. Ashwani Sood
Dr. Ashwani Sood

Dr. Ashwani Sood

Nuclear Medicine

Rohilkhand Cancer Institute

NameNameDr. Ashwani Sood
Father’s NameFather’s NameLate Sh. O.P. Kashyap
Date of BirthDate of Birth10.10.1960
NationalityNationalityIndian
Permanent AddressPermanent AddressDr. Ashwani Sood,
House No 1417 First Floor,
Sector-40 B, Chandigarh-160036, India
EmailEmailsood99@yahoo.com

Qualification:

S. NoExaminationYearCollege/InstitutionUniversity/Board
1.M.B.B.S.1985Indira Gandhi Medical College, ShimlaH.P. University, Shimla
2.D.R.M.1993Radiation Medicine Centre, (BARC), MumbaiUniversity of Mumbai, Mumbai
3.DNB
(Nuclear Medicine)
2000Sanjay Gandhi Post Graduate Institute of Medical Sciences, LucknowNational Board of Exam. Delhi

Research Work Done:

  • DTPA clearance of submicronic particles in changing concentration of saline in non-smokers and smokers. (DRM Dissertation)
  • Semi Solid Bolus Esophageal Transit Scintigraphy in normal volunteers and patients of Esophageal Motor Disorders. (DNB Thesis)

Honours:

  • Member of National Academy of Medical Sciences (India) (MNAMS) in year 2004
  • Fellow of Indian College of Nuclear Medicine (FICNM) in year 2021

Working Experience:

(Total period of service – more than 30 years)

  • Worked as House Surgeon in Dept. of Radiotherapy, I.G. Medical College, Shimla - 6 months
  • Worked as House Surgeon in Dept. of Chest & T.B., I.G. Medical College, Shimla 6 months
  • Worked as Medical Officer in State Health Services (Govt. of H.P.) – 4 yrs. & 4 months.
  • Worked as Registrar in Dept. of Radiotherapy, I.G. Medical College, Shimla –2 yrs.
  • Worked as Medical Officer (Nuclear Medicine) in Dept. of Radiotherapy, Regional Cancer Centre, I.G. Medical College, Shimla- 6 yrs. & 6 months
  • Worked as Senior Resident (Nuclear Medicine) in Dept. of Radiotherapy, Regional Cancer Centre, I.G. Medical College, Shimla- 4 yrs
  • Worked as Assistant Professor (Nuclear Medicine) in Dept. of Radiotherapy, Regional Cancer Centre, I.G. Medical College, Shimla- 4yrs & 3months
  • Worked as Assistant Professor in Dept. of Nuclear Medicine, PGIMER, Chandigarh – 3years
  • Worked as Associate Professor in Dept. of Nuclear Medicine, PGIMER, Chandigarh – 3years
  • Worked as Additional Professor in Dept. of Nuclear Medicine, PGIMER, Chandigarh – 4 years
  • Worked as Professor in Dept. of Nuclear Medicine, PGIMER, Chandigarh - 4 yrs & 4 months
  • Worked as Professor & Head in Dept. of Nuclear Medicine, SAIMS, Indore - ~ 5 months

Training:

  • DRM trainee in Nuclear Medicine, Radiation Medicine Centre, BARC, Mumbai-1 yr.
  • Sr. Resident in Dept. of Nuclear Medicine, Sanjay Gandhi Post Graduate Institute Medical Sciences, Lucknow –1yr & 7 months.
  • Radiation Safety Officer – Radiation Safety Course at BARC, Mumbai
  • Training for sentinel node lymphoscintigraphy in early breast cancer at St Vincent Hospital, New York, USA-2 months
  • Clinical Nuclear Medicine training at different hospitals in Budapest, Hungary-1 month
  • WHO-In-Country Fellowship in Diagnostic Medical Physics at AIIMS, New Delhi -2 months
  • Regional Training Workshop (IAEA) in Myocardium Perfusion Scintigraphy using SPECT for Nuclear Medicine Physician, New Delhi, Dec 2000.
  • Regional Training Course (IAEA) on “Essentials of Hybrid Nuclear Medicine Imaging” at Chiangmai, Thailand Dec 2014

Teaching Experience:

Teaching Clinical Nuclear Medicine to Undergraduate\Postgraduate students of the institution

Achievements & Awards:

  1. Joint Secretary for 4th Annual Conference of North Zone, Association of Radiation Oncologists of India, Shimla, November 1997
  2. ICRETT Fellowship (UICC, Switzerland) at St. Vincent’s Hospital, New York, USA from July-August, 2002 for 2 months
  3. Asia–Oceania Distinguished Young Investigator’s Award 2003 presented by Japanese Society of Nuclear Medicine, Tokyo, Japan
  4. Joint Secretary for XIth Annual Conference of North Zone, Association of Radiation Oncologists of India, Shimla, October 2005
  5. WHO-In-Country Fellowship 2007 in Diagnostic Medical Physics at AIIMS, New Delhi for 2 months
  6. Project sanctioned by UGC, New Delhi 2008 for Minor Research Grant as Principal Investigator “To evaluate the role of Tc99m MIBI scintimammography for the assessment of neo-adjuvant chemotherapy response in locally advanced breast cancer” for 2 years
  7. Organizing Secretary for CME titled “Therapeutic Applications of Nuclear Medicine” on occasion of PGIMER Golden Jubilee celebration at PGIMER, Chandigarh 22nd -23rd September 2012
  8. Chief Scientific Investigator for IAEA Research Project PERTAIN, Vienna, Austria
  9. Treasurer for Indian Journal of Nuclear Medicine (official journal of Society of Nuclear Medicine-India)
  10. Treasurer of Nuclear Cardiological Society of India 2013-15 and 2015-17
  11. Patent under-process by Patent Office, Govt of India for use of UDCA in 99mTc-MIBI in myocardial perfusion scintigraphy Aug 2018
  12. Institute Award for an original article on Institute Research Day 2018, PGIMER, Chandigarh
  13. Chief Scientific Investigator for IAEA Research Project iCOS (2019-24), Vienna, Austria
  14. Secondary Chief Scientific Investigator for IAEA Research Project PIAF (2019-2024), Vienna, Austria
  15. Secondary Chief Scientific Investigator for IAEA Research Project iTAC (2021-2025), Vienna, Austria
  16. Professor Ralph Blumhardt Award for Best ACNM Nuclear Medicine Research Award in SNMMI Mid-Winter and ACNM Annual Meeting USA 2022
  17. Indo-American Society of Nuclear Medicine IASNM Disruptive Nuclear Intervention Award for best Research Paper in SNMMI 2022, Vancouver, Canada
  18. Korean Society of Medical Oncology Travel Grant for poster presentation in KSMO 2023 Seoul, South Korea, Sept 2023
  19. Brig SK Mazumdar Oration award, SNMICON 2023 at AIIMS, Jodhpur Nov 2023
  20. Awarded “Best of Best Award” and “Best Abstract Award” in IPET 2024 at Vienna, Austria Oct 2024

Chapters in Book: 5

  1. “Role of coronary flow reserve in coronary artery disease” in book “Cardiac Imaging Update 2019” by Jaypee Brothers Medical Publishers (P) Ltd. India
  2. “Quantitative Assessment of Myocardial Blood Flow & Fractional Flow Reserve (FFR) & their Clinical Applications” in book “Advances in Clinical Cardiovascular Imaging, Echocardiography & Interventions (ACCIEI): Textbook of Cardiology” by Jaypee Brothers Medical Publishers (P) Ltd. India
  3. “Cardiac PET versus MRI for the Evaluation of Infiltrative Diseases of Heart “in book “Cardiac Imaging Update 2019” by Elsevier India
  4. “Role of Cardiovascular Nuclear Medicine in Systolic and Diastolic Heart Failure” in book “Cardiac Imaging Updates-2023” by Evangel Publishing, India
  5. “Thyroid Imaging and Therapy” in book “Targeted Radiopharmaceuticals and Imaging: Challenges and Opportunities” by Royal Society of Chemistry, Cambridge CB4 0WF, UK

Publications:

  1. Aggarwal P, Sood A, Satapathy S, Goyal S, Kaur K, Prakash G, Periasamy K, Mittal BR. [177Lu]Lu-PSMA-617 Plus Short-Course Priming With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Single-Arm Phase 2 Trial (Lu-PRIME). Prostate. 2026 Sep 13. doi: 10.1002/pros.70253. 
  2. Jamwal A, Sood S, Aggarwal P, Mardi K, Sood A. A Diagnostic Ambiguity: The Indispensable Role of Tc-99m Sulphur Colloid Scan in Differentiating Pancreatic Neuroendocrine Tumour from Splenunculus. Indian J Nucl Med. doi: 10.25259 /IJNM_90_2026
  3. Jamwal A, Mahdi RA, Satapathy S, Aggarwal P, Biswas D, Sarin V, Mitra S, Sood A. Iodine Avid Muscle Metastases Mimicking Skeletal Lesions on Whole-Body Iodine Scan in Poorly Differentiated Thyroid Carcinoma -SPECT/CT to the Rescue. Clin Nucl Med. 2026 Jul 21. doi: 10.1097/RLU.0000000000006632. 
  4. Aggarwal P, Sood A, Khosla D, Kapoor R, Prakash G, Dahiya D, Bhadada SK, Walia R, Gupta R, Mittal BR. Efficacy and safety of peptide receptor radionuclide therapy in advanced foregut and hindgut neuroendocrine tumors: a real-world experience from a single institution. Ann Nucl Med. 2026 Jun 3. doi: 10.1007/s12149-026-02241-w.
  5. Jamwal A, Aggarwal P, Sood A, Sood A, Aggarwal A, Mittal BR. Respiratory Infection Masquerading as Disease Progression on 177 Lu-DOTATATE Post Therapy Scan. Nucl Med Mol Imaging (2026). https://doi.org/10.1007/s13139-026-01025-4
  6. Aggarwal P, Satapathy S, Kumar S, Sood A, Lal A, Walia R, et al. Gas in liver: Atypical response in metastatic adrenocortical carcinoma on cabozantinib therapy. Nucl Med Mol Imaging (2026). https://doi.org/10.1007/s13139-026-01023-6
  7. Aggarwal P, Rathi S, Sood A, Kapoor R, Mittal BR. Multidisciplinary Management of Metastatic Pancreatic Neuroendocrine Tumor Using a Combination of Beta, Alpha Radionuclide and Ethanol Ablation Therapies. Clin Nucl Med. 2026 Apr 21. doi: 10.1097/RLU.0000000000006409. 
  8. Solanki R, Sood A, Bahl A, Dhooria S, Singhal M, Singh S, Debi U, Mehrotra S, Singh H, Mittal BR. Diagnostic performance of 68Ga-DOTANOC PET/computed tomography in cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose PET/computed tomography and cardiac magnetic resonance. Nucl Med Commun. 2026 Jan 29. doi: 10.1097/MNM.0000000000002113.
  9. Komal Preet, Ashwani Sood, Swayamjeet Satpathy, et al. 68Ga-PSMA-11 PET/CT Versus Conventional Imaging for Response Evaluation in Metastatic Castration-resistant Prostate Cancer A Single-center Prospective Study. Clin Nucl Med. 2025 Nov. DOI: 10.1097/RLU.0000000000006147
  10. Yadav BS, Sood A, Dahiya D. Late cardiac effects in patients with left breast cancer treated with hypofractionated radiotherapy. Rep Pract Oncol Radiother. 2025 Dec 31;30(6):781-788.
  11. Md YArafath, Uma Debi, Manphool Singhal, Ashwini Sood, Rohit Kumar Manoj. Comparison of Cardiac MR with PET/CT in Evaluation of Myocardial Viability: Single-Center Experience. Ind J Radiol Imaging. doi.org/10.1055/s-0045-1811583.
  12. Aryal AB, Kaur K, Aggarwal P, Madan R, Chatterjee, D, Kaur G, Sood A, Mittal BR. CNS Neuroendocrine Tumour with Discordant SSTR Imaging: Redefining Patient Stratification for PRRT. Nucl Med Mol Imaging. 2026;60:441–442.
  13. Vinisha Gunasekaran, Harpreet Singh, Prashant Panda, Dinkar Bhasin, Yashpaul Sharma, Ashwani Sood, Bhagwant Rai Mittal. Assessment of Coronary Microvascular Dysfunction in INOCA Patients Using 13N-Ammonia-PET: Lack of Correlation with Angiographic Flow Grades. J Nucl Med. 2025 Dec doi.org/10.1016/j.nuclcard.2025.102596
  14. Aggarwal P, Satapathy S, Chandekar KR, Sood A. Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN). Semin Nucl Med. 2025 Dec 3:S0001-2998(25)00161-8. doi: 10.1053/j.semnuclmed.2025.11.009
  15. Meena A, Subramanian K, Sood A, Mittal BR. Rare presentation of mandibularmetastases from differentiated thyroid carcinoma: A case series – Experience from a single tertiary care hospital. Indian J Nucl Med 2025;40:304-8.
  16. Kumari N, Rastogi P, Singh N, Das R, Sharma P, Sood A, Parmar M, Hira JK, Trehan A, Khadwal AR, Khandelwal N. Cardiac dysfunction in transfusion-dependent β-thalassaemia: Insights into apolipoprotein E genotypes and iron metrics in a north Indian cohort. Br J Haematol. 2025 Jun 10. doi: 10.1111/bjh.20201.
  17. Aggarwal P, Satapathy S, Sood A, Singh P, Singh H, Chopra S, Prakash G, Mittal BR. Recurrent pulmonary lymphangitis carcinomatosis detected on 177Lu-PSMA-617 post-therapy scan in mCRPC with negative PSMA PET and HRCT. Eur J Nucl Med Mol Imaging. 2025 Jun 6. doi: 10.1007/s00259-025-07392-y.
  18. Satapathy S, Aggarwal P, Sood A, Chandekar KR, Das CK, Gupta R, Khosla D, Das N, Kapoor R, Kumar R, Singh H, Mittal BR. Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [177Lu]Lu-DOTATATE therapy: post-hoc analysis of the phase 2 LuCAP trial. Eur J Nucl Med Mol Imaging. 2025 May 26. doi: 10.1007/s00259-025-07351-7. 
  19. Satapathy S, Das CK, Goyal S, Sood A, Periasamy K, Aggarwal P, Preet K, Singh SK, Mavuduru RS, Bora GS, Sharma AP, Prakash G, Kumar R, Singh H, Mittal BR. 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial. J Nucl Med. 2025 May 22:jnumed.125.269913. doi: 10.2967/jnumed.125.269913.  
  20. Aggarwal P, Satapathy S, Kaur G, Sood A, Bhadada SK, Walia R, Gupta R, Mittal BR. Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Multiple Endocrine Neoplasia Syndrome: A Single-center Experience. Clin Nucl Med. 2025 May 19. doi: 10.1097/RLU.0000000000005891.
  21. Mahdi RA, Preet K, Sood A, Shankar K, Mittal BR. Role of SPECT/CT in Serendipitous Finding of Urinary Bladder Hernia in 99mTc-labelled RBC Scintigraphy. Nucl Med Mol Imaging. 2025 Aug;59(4):274-276. 
  22. Mahdi RA, Ilangovan J, Singh H, Mittal BR, Kumar R, Sood A, Goyal S. Rare Urachal Metastases in Prostate Cancer: A Case Highlighting the Utility of 18F-PSMA-1007 PET/CT. Nucl Med Mol Imaging. 2025:272-273. 
  23. Aggarwal P, Satapathy S, Sarungbam B, Sood A, Kumar R, Goyal S, Mittal BR. Exceptional Response to Rechallenge Peptide Receptor Radionuclide Therapy in Metastatic Carotid Body Tumor. Clin Nucl Med. 2025 Apr 30. doi: 10.1097/RLU.0000000000005930.
  24. Aggarwal P, Mathur Y, Sood A, Kumar R, Mittal BR. Metastatic Mimicker in Thyroid Cancer with Thyroglobulin Elevation and an FDG-Avid Recurrent Aneurysmal Bone Cyst. J Nucl Med Technol. 2025 Apr 1:jnmt.124.269415. doi: 10.2967/jnmt.124.269415.
  25. Aggarwal P, Sharma M, Kumar R, Singh H, Mittal BR, Sood A. 68Ga-PSMA Uptake in Subchondral Cyst Giving a False Impression of Disease Progression after 177Lu-PSMA Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer. Nucl Med Mol Imaging. 2025 Apr;59(2):154-155.
  26. Aggarwal P, Anwariya A, Kaur K, Satapathy S, Sood A, Singh N, Bal A, Singh H, Mittal BR. PSMA-based Theranostics in Advanced Non-small Cell Lung Cancer​​​​​​: A Hit or a Miss? Clin Nucl Med. 2025 Mar 11. doi: 10.1097/RLU.0000000000005816.
  27. Aggarwal P, Kaur G, Bhadada SK, Kumar R, Pandey S, Sood A, Mittal BR. Mirrored Metastatic Neuroendocrine Tumor in a Mother-Daughter Duo With Mutations in the MEN1 Gene. Clin Nucl Med. 2025 Feb 28. doi: 10.1097/RLU.0000000000005732.
  28. Prashar, Sarika Sharma; Kumar, Ajay; Sood, Ashwani; Mittal, Bhagwant Rai. Onsite Regeneration of Crystal Data in a 3/8” Foresight Detector Using a Digital Workflow. Indian J Nucl Med 39(5):p 411-414, Sep–Oct 2024. 
  29. Aggarwal, Piyush; Krishnaraju, Venkata Subramanian; Sood, Ashwani; Mathur, Yamini; Bhattacharya, Anish; Mittal, Bhagwant Rai. Utility of Cross-sectional and Correlative Imaging in Differentiated Thyroid Carcinoma with Unusual Presentation of Adrenal Metastases – Case Series and Review of Literature. Indian J Nucl Med 39(5):p 399-405, Sep–Oct 2024.
  30. Kumar SA, Sood A, Kumar R, Pandey S, Shukla J, Mittal BR, Satz S. Exploring the Role of [68Ga]Ga-DOTAGA-IAC and Comparison of Its Diagnostic Performance with [18F]F-FDG PET/CT in Radioiodine Refractory Differentiated Thyroid Carcinoma. Cancer Biother Radiopharm. 2025 Jan 13. doi: 10.1089/cbr.2024.0166.
  31. Satapathy S, Aggarwal P, Sood A, Chandekar KR, Das CK, Gupta R, Khosla D, Das N, Kapoor R, Kumar R, Singh H, Shukla J, Kumar A, Mittal BR. 177Lu-DOTATATE Plus Capecitabine Versus 177Lu-DOTATATE Alone in Patients with Advanced Grade 1/2 Gastroenteropancreatic Neuroendocrine Tumors (LuCAP): A Randomized, Phase 2 Trial. J Nucl Med. 2025 Jan 8:jnumed.124.268617. doi: 10.2967/jnumed.124.268617. 
  32. Aggarwal P, Gunasekaran V, Sood A, Mittal BR. Localization in primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2024 Dec 30:101967. doi: 10.1016/j.beem.2024.101967.
  33. Aggarwal P, Gunasekaran V, Sood A, Kumar N, Rathore Y, Kumar R, Mittal BR. Re-Rechallenge 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Step Further. Clin Nucl Med. 2024 Nov 19. doi: 10.1097/RLU.0000000000005589. 
  34. Mahdi RA, Saraswat D, Aggarwal P, Sood A, Kumar M, Mittal BR. Uncovering Hidden Metastases at Unusual Site: Emphasizing the Role of 177Lu-PSMA Posttherapy Scan in Detecting Rare Foot Metastasis in mCRPC. Clin Nucl Med. 2025 Feb 1;50(2):e118-e119. 
  35. Kumar S, Kundu R, Jayanna SH, Aggarwal P, Sood A, Rana SS. Prostatic Adenocarcinoma Taking an Unusual Route: Rare Case of Pancreatic Metastasis. Dig Dis Sci. 2024 Nov 4. doi: 10.1007/s10620-024-08706-0.
  36. Aggarwal P, Gunasekaran V, Gowtham M, Mahajan JK, Sood A, Mittal BR, Menon P, Peters NJ, Malik MA, Bhattacharya A. Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by 99mTc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging. Ann Nucl Med. 2024 Nov 1. doi: 10.1007/s12149-024-01994-6.
  37. Kumari P, Garg S, Bhadada SK, Pal R, Mukherjee S, Lohani S, Basoya R, Dahiya D, Singla V, Sood A. Prevalence, risk factors and effect of curative parathyroidectomy on nephrocalcinosis in Asian-Indian patients with symptomatic primary hyperparathyroidism. J Endocrinol Invest. 2024 Oct 12. doi: 10.1007/s40618-024-02464-6. 
  38. Aggarwal P, Gupta K, Sood A, Bora GS, Goyal S, Singh H, Mittal BR. Simultaneous Metastatic Involvement of Bilateral Testes and Left Spermatic Cord in Prostate Cancer Detected on 68Ga-PSMA-11 PET/CT. Clin Nucl Med. 2024 Sep 25. doi: 10.1097/RLU.0000000000005466.
  39. Kopp CR, Sharma SK, Krishnaraju VS, Sood A, Kumar R, Sinha A, Dhooria S, Singh J, Anand S, Minz RW, Dhir V, Jain S. Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). 2024 Sep 23:keae503. doi: 10.1093/rheumatology/keae503.
  40. Aggarwal P, Satapathy S, Sood A, Singh H, Mittal BR, Lal S, Gupta R, Das CK, Yadav TD, Walia R. Safety and Efficacy of 177 Lu-DOTATATE in Children and Young Adult Population : A Single-Center Experience. Clin Nucl Med. 2024 Jul 1;49(7):e312-e318
  41. Aggarwal P, Ambalavanan N, Sood A, Gupta K, Dahiya D, Mittal BR. Prostate-Specific Membrane Antigen-Avid Neurofibroma Mimicking Cutaneous Metastasis in Metastatic Castration-Resistant Prostate Cancer on 18F-PSMA-1007 PET/CT. Clin Nucl Med. 2024 Apr 8.
  42. Singh B, Kundu R, Mitra S, Bhujade H, Sood A, Samanta J, Gupta V. Duodenal gastrointestinal stromal tumor masquerading as an uncinate process pancreatic neoplasm. Diagn Cytopathol. 2024 Apr 2. doi: 10.1002/dc.25315.
  43. Aggarwal P, Kumar A, Sood A, Walia R, Bhadada SK, Mittal BR. 177Lu-DOTATATE Salvage Therapy in Rapidly Progressing Neuroendocrine Tumor With Poor Performance Status. Clin Nucl Med. 2024 Mar 18. doi: 10.1097/RLU.0000000000005177.
  44. Aggarwal P, Sood A, Kumar R, Singh H, Singh H, Bhatia V, Mittal BR. Unusual Sites of Visceral Spread in Prostate Cancer: A Prostate-Specific Membrane Antigen-Based Theranostic Imaging Series. Clin Nucl Med. 2024 May 1;49(5):e222-e226. 
  45. Mahato S, Aggarwal P, Thunga C, Sood A, Kanojia R P, Nada R, Lal SB. Neoadjuvant Peptide Receptor Radionuclide Therapy in a Rare Case of Pediatric Primary Hepatic Gastrinoma. Clin Nucl Med. 2024;49(4):e161-e163.
  46. Solanki R, Singh H, Mehta V, Panda P, Singhal M, Sood A, Mittal BR. Potential application of 68Ga-FAPI PET/CT for diagnosing cardiac sarcoidosis. J Nucl Cardiol. 2024 Feb 23:101835. doi: 10.1016/j.nuclcard.2024.101835.
  47. Veerwal H, Preet K, Sood A, Singh H, Parmar M, Mittal BR. Incidentally detected diaphragmatic eventration as para-cardiac thoracic activity on myocardial perfusion imaging. J Nucl Cardiol. Published online January 30, 2024. doi:10.1016/j.nuclcard.2024.101817
  48. Sathekge MM, Lawal IO, Bal C, Bruchertseifer F, Ballal, S, Cardaci G, Davis C, Eiber M, Hekimsoy T, Knoesen O, Kratochwil C, Lenzo NP, Mokoala KMG, Ndlovu H, Pant V, Rathke H, Reed J, Sen IB, Singh A, Sood A, Tauber R, Thakral P, Yadav MP, Morgenstern A. Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study. Lancet Oncol. 2024 Feb;25(2):175-183
  49. Baloji A, Kalra N, Chaluvasthetty S, Bhujade H, Chandel K, Duseja A, Taneja S, Gorsi U, Kumar R, Singh H, Sood A, Bhattacharya A, Singh B, Mittal BR, Singh V, Sandhu MS. Efficacy of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma: An Experience With Hybrid Angio-Computed Tomography and Glass Microspheres. J Clin Exp Hepatol. Vol 14 3: Ma-June 2024, 101342.
  50. Aggarwal P, Gunasekaran V, Sood A, Gupta K, Das CK, Mittal BR. Sunitinib in Tandem With 177Lu-DOTATATE Therapy in Advanced Pancreatic Neuroendocrine Tumor: A New Treatment Approach. Clin Nucl Med. Dec, 2023. doi:10.1097/RLU.0000000000005018
  51. Kaur K, Nagi S, Satapathy S, Aggarwal P, Sood A, Mittal BR. Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177 Lu- PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single-center feasibility study. Nucl Med Commun. 2023;10.1097/MNM.0000000000001792.
  52. Kumar SA, Meena A, Sood A, Kumar R, Mittal, BR. Tubarial salivary glands on PSMA ligands based PET imaging and post 177Lu PSMA therapy scan: reiterating its importance. Asia Ocean J Nucl Med Biol. 2024;12(1)
  53. Shah R, Das L, Dutta P, Sood A, Bhadada SK. A rare case of headache in a patient with McCune-Albright Syndrome: A triple threat. Cureus. 2023 Sep 14;15(9):e45249.
  54. Satapathy S, Mittal BR, Sood A, et al. [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial [published online ahead of print, 2023 Sep 14]. J Nucl Med. 2023. doi:10.2967/jnumed.123.266141
  55. Mahdi RA, Aggarwal P, Kumar S, Sood A, Paul D, Mittal BR. Excellent Response to Full-Dose 177 Lu-PSMA-617 RLT in Metastatic Castration-Resistant Prostate Cancer With Transplant Kidney : A Step Ahead. Clin Nucl Med. 2023;48(10):e470-e471.
  56. Banerjee S, Nahar U, Dahiya D, Gupta R, Mukherjee S, Sachdeva N, Sood A, Dey P, Radotra B, Bhansali A . IL-17 A correlates with disease progression in papillary thyroid carcinoma. Diagn Pathol. 2023;18(1):93.
  57. Solanki R, Parikshaa Gupta P, Sood A, Mittal BR. Breast Metastasis Arising from Ileal Neuroendocrine Tumor: an Unusual Presentation. Nuclear Medicine and Molecular Imaginghttps://doi.org/10.1007/s13139-023-00792-8.
  58. Subramanian K, Mittal BR, Singh H, Sood A. Stigmata of portal hypertension depicted on myocardial perfusion imaging. J Nucl Cardiol. 2023 Mar 10. doi: 10.1007/s12350-023-03229-z.
  59. Chopra S, Singh SS, Sood A, Parmar M, Parihar AS, Vadi SK, Mittal BR. Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction. J Nucl Cardiol. 2023 Feb 27. doi: 10.1007/s12350-023-03210-w.
  60. Subramanian K, Mahdi R, Singh H, Sood A, Mittal BR. Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm. J Nucl Cardiol. 2023 Feb 21. doi: 10.1007/s12350-023-03223-5.
  61. Aggarwal P, Anwariya A, Kavanal AJ, Sood A, Jena SR, Mittal BR. Hot Embolus Artifact Mimicking Disease Progression in Post-therapy 177Lu-DOTATATE Scan: Incremental Value of SPECT/CT. Nucl Med Mol Imaging (2023). https://doi.org/10.1007/s13139-023-00789-3
  62. Aggarwal P, Kaur K, Sood A, Periasamy K, Nagi S, Mittal BR. Increased PSMA Expression in 177Lu-PSMA-617 Scan in Metastatic Castrate-Resistant Prostate Cancer Patient treated with PSMA Radioligand Therapy and Enzalutamide: A Potential Game-Changer. Clin Nucl Med. 2023 Jan 12. doi: 10.1097/RLU.0000000000004529. 
  63. Anwariya A, Aggarwal P, Sood A, Tigapuram N, Prashar S. False positive finding on whole-body iodine-131 scan secondary to contaminated face mask: an uncommon peril in current COVID pandemic. Asia Oceania J Nucl Med and Biol, 2023; 11(1): 82-84. 
  64. Aggarwal P, Seenivasagam RK, Sood A, Prashar S, Pathak P, Sachdeva N, Gupta P. Radioactive iodine uptake in post-operative seroma: a cause for false positivity. J Nucl Med Technol November 2022, jnmt.122.264569. 
  65. Banerjee S, Nahar U, Dahiya D, Mukherjee S, Dey P, Gupta R, Radotra B, Sachdeva N, Sood A, Bhadada SK, Bhansali A. Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2022 Nov 28;13:931647. doi: 10.3389/fendo.2022.931647.
  66. Kaur Gurvinder, Shukla Jaya, Sood Ashwani, Prakash Gaurav, Krishnaraju Venkata Subramanian, Rana Nivedita, Pandey Somit, Singh Harmandeep, Kumar Rajender, Bal Amanjit, Mittal Bhagwant Rai. Potential Role of 68Ga-NOTA-Duramycin PET/CT Imaging for Early Response Evaluation in a Lymphoma Patient: A Case Report. Clin Nucl Med: October 20, 2022 - Volume - Issue - 10.1097/RLU.0000000000004462 
  67. Satapathy S, Das CK, Aggarwal P, Sood A, Parihar AS, Singh SK, Mittal BR. Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience. Prostate. 2022 Oct 19. doi: 10.1002/pros.24450.
  68. Shastri M, Kundu R, Krishnaraju VS, Bhujade H, Bhandari RM, Sood A. Cystic hepatic metastases in treatment naïve neuroendocrine tumor: Cytomorphology clubbed with cell block immunocytochemistry clinches the diagnosis. Diagnostic Cytopathology. 2022;1‐4. doi:10.1002/ dc.25047
  69. Singh SS, Mittal BR, Sood A, Bhattacharya A, Kumar G, Shekhawat AS, Singh H. Applicability of Adults 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines for Postoperative Risk Stratification and Postradioiodine Treatment Dynamic Risk Stratification in Pediatric Population. World J Nucl Med. 2022 Jul 19;21(2):127-136.
  70. Dhiman D, Vatsa R, Sood A. Challenges and opportunities in developing Actinium-225 radiopharmaceuticals. Nucl Med Commun. 2022 Sep 1;43(9):970-977
  71. Mishra AK, Singh H, Bansal V, Raja J, Sood A. Nuclear cardiology for a cardiothoracic surgeon. Indian J Thorac Cardiovasc Surg. 2022 May;38(3):268-282.
  72. Swayamjeet Satapathy, Amit Sharma, Ashwani Sood, Pooja Maheshwari, Harinder Jit Singh Gill. Delayed Nephrotoxicity after 225Ac-PSMA-617 Radioligand Therapy. Clin Nucl Med 2022. DOI: 10.1097/RLU.0000000000004149
  73. Sindhu Tanigassalam, Venkata Subramanian Krishnaraju, Ashwani Sood, Piyush Aggarwal, Anish Bhattacharya, Deepak Bansal, Pritam Singha Roy. Bilaterally ectopic pelvis kidneys masquerading as horseshoe kidney in Fanconi anemia. Journal of Nuclear Medicine Technology February 2022, jnmt.121.263543; DOI: https://doi.org/10.2967/jnmt.121.263543
  74. Kishore Abuji, Divya Dahiya, Ashwani Sood, Madan Parmar, Sanjay Kumar Bhadada, Rajesh Vijayvergiya, Arunanshu Behera. Impact of curative parathyroidectomy on left ventricular functions assessed with 2D ECHO and MUGA study. Turk J Surg. 2021, Vol 37(4):336-341
  75. Liza Das, Ashutosh Rai, Pravin Salunke, Chirag Kamal Ahuja, Ashwani Sood, Bishan Dass Radotra, Ridhi Sood, Márta Korbonits, Pinaki Dutta. Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes. J Endocr Soc, Volume 6, Issue 2, February 2022, bvab190, https://doi.org/10.1210/jendso/bvab190
  76. Kumar M, Subramanian K, Tanwar KS, Prabhahar A, Divyaveer S, Sood A, Mittal BR, Sood A. Radioiodine therapy in patient of differentiated thyroid cancer with end-stage renal disease on maintenance hemodialysis: case report with review of literature. J Nucl Med Technol. 2021 Dec 6:jnmt.121.261979. doi: 10.2967/jnmt.121.261979
  77. Satapathy S, Mittal B, Sood A. et al. 177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial. Eur J Nucl Med Mol Imaging 2022 Apr;49(5):1754-1764.
  78. Liza Das, Vandana Dhiman, Pinaki Dutta, Ashwani Sood, Mahesh Prakash, Simran Kaur, Ellen Steenackers, Gretl Hendrickx, Devi Dayal, Wim Van Hul, Sanjay Kumar Bhadada, Camurati-Engelmann disease complicated by hypopituitarism: Management challenges and literature review of outcomes with bisphosphonates. AACE Clinical Case Reports, 2021, https://doi.org/10.1016/j.aace.2021.10.002
  79. Aggarwal P, Chandekar KR, Sood A. et al. Incidental Muscle Uptake of 177Lu-DOTATATE in Peripheral Vascular Disease. Nucl Med Mol Imaging 55, 320–322 (2021).
  80. Krishnaraju V, Upadhyay R, Sood A, Bhattacharya A, Mittal B. Toxic thyroid adenoma with hypercalcemia mimicking an intra-thyroidal parathyroid adenoma. Asia Oceania Journal of Nuclear Medicine and Biology, 2021; doi: 10.22038/aojnmb.2021.57103.1398
  81. Das L, Bhadada SK, Sood A. Post-COVID-vaccine autoimmune/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis. J Endocrinol Invest (2021). https://doi.org/10.1007/s40618-021-01681-7.
  82. Kumari P, Arya AK, Pal R, Sood A, Dahiya D, Mukherjee S, Rastogi A, Bhadada SK. Comparison of Profile of Primary Hyperparathyroidism With and Without Type 2 Diabetes Mellitus: Retrospective Analysis From the Indian Primary Hyperparathyroidism Registry. Endocr Pract. 2021 Sep 30:S1530-891X(21)01243-X. doi: 10.1016/j.eprac.2021.09.012.
  83. Dahiya D, Abuji K, Kumari P, Gautam A, Bhadada S, Sood A, Nahar U, Tandup C, Behera A. Surgical outcome after focused parathyroidectomy: experience from a tertiary care centre in North India. Pol Przegl Chir. 2021 May 15;93(5):1-5.
  84. Kavanal AJ, Satapathy S, Sood A, Khosla D, Mittal BR. Subclinical Hypothyroidism After 225Ac-DOTATATE Therapy in a Case of Metastatic Neuroendocrine Tumor: Unknown Adverse Effect of PRRT. Clin Nucl Med. 2021 Sep 8. doi: 10.1097/RLU.0000000000003893.
  85. Dinesh Nalbo, Divya Dahiya, Ashwani Sood, Sanjay Kumar Bhadada, Arunanshu Behera, Uma Nahar. Surgical outcome of radioguided parathyroidectomy in primary hyperparathyroidism. Int Surg J. 2021 Feb;8(2):681-685
  86. Parkhi M, Chatterjee D, Bardia A, Kanaval AJ, Sood A, Saikia UN, Bansal N. Papillary thyroid carcinoma with nodular fasciitis-like stroma: a rare variant. Autops Case Rep. 2021 Aug 20;11:e2021320. doi: 10.4322/acr.2021.320.
  87. Vadi SK, Sood A, Khadwal A, Parmar M, Bhatia A, Kashyap S, Bahl A, Mittal BR. Exploring the potential utilities of 99mTc-labeled RBC-equilibrium radionuclide angiocardiography in transfusion-dependent β-thalassemia major patients. Nucl Med Commun. 2021 Aug 9. doi: 10.1097/MNM.0000000000001467. 
  88. Das L, Bhadada SK, Arvindbhai SM, Dahiya D, Behera A, Dutta P, Bhansali A, Sood A, Singh P, Prakash M, Kumari P, Rao SD. Baseline renal dysfunction determines mortality following parathyroidectomy in primary hyperparathyroidism: analysis of Indian PHPT registry. J Bone Miner Metab. 2021 Aug 15. doi: 10.1007/s00774-021-01256-9.
  89. Satapathy S, Mittal BR, Sood A, Sood A, Kapoor R, Gupta R, Khosla D. 177Lu-DOTATATE Plus Radiosensitizing Capecitabine Versus Octreotide Long-Acting Release as First-Line Systemic Therapy in Advanced Grade 1 or 2 Gastroenteropancreatic Neuroendocrine Tumors: A Single-Institution Experience. JCO Glob Oncol. 2021 Jul;7:1167-1175. doi: 10.1200/GO.21.00103.
  90. Satapathy S, Sood A, Das CK, Kavanal AJ, Mittal BR. Alpha Before Beta: Exceptional Response to First-Line 225Ac-DOTATATE in a Patient of Metastatic Neuroendocrine Tumor With Extensive Skeletal Involvement. Clin Nucl Med. 2021 Jul 20. doi: 10.1097/RLU.0000000000003823.
  91. Satapathy S, Bhattacharya A, Sood A, Kapoor R, Gupta R, Sood A, Sharma P, Khosla D, Mittal BR. Hematological Markers as Predictors of Treatment Outcomes with Lu-177 DOTATATE in Patients with Advanced Neuroendocrine Tumors. Cancer Biother Radiopharm. 2021 Jun 29. doi: 10.1089/cbr.2021.0053.
  92. Swayamjeet Satapathy, Namrata Das, Ashwani Sood, Shikha Goyal, Renu Madan, Bhagwant R. Mittal. Short-course 177Lu-PSMA-617 Radioligand Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer: Time to Take the Leap? Euro Uro. 2021 Sep;80(3):390-392
  93. Otaal PS, Shah A, Batta A, Sood A, Pal A. Clinical and angiographic prophesy of hemodynamic status in patients with acute anterior wall ST-segment elevation myocardial infarction and totally occluded left anterior descending artery. Integrated Blood Pressure Control 2021: 14: 89-97.
  94. Vatsa R, Sood A. Theranostic role of radiolabeled RGD peptides in the treatment of radioiodine-resistant thyroid cancer: a novel agent. January 2020. The Indian Journal of Medical Research 152(7):258.
  95. Krishnaraju VS, Kumar R, Sood A, Shukla J, Subramanian K, Kakkar N, Panda N, Mittal BR. Angiogenesis-Targeted 68Ga-DOTA-RGD2 PET/CT Imaging: a Potential Theranostic Application in the Case of Chondrosarcoma. Nucl Med Mol Imaging. 2021 Jun;55(3):141-145.
  96. Bollampally N, Krishnaraju VS, Sood A, Aggarwal S, Mittal BR. Osteogenic Sarcoma Presenting with Skip, Lymph Nodal, Pulmonary, Pleural Metastases and Malignant Effusion: An Unusual Appearance on Bone Scan. Indian J Nucl Med. 2021 Jan-Mar;36(1):78-79.
  97. Bollampally N, Shukla J, Mittal BR, Sood A, Mohanty M, Kapoor R, Vatsa R, Satapathy S, Chakravarty R, Chakraborty S, Dash AAK. Efficacy and safety of 177Lu-DOTMP in palliative treatment of symptomatic skeletal metastases: a prospective study. Nucl Med Commun. 2021 Apr 12. doi: 10.1097/MNM.0000000000001425. 
  98. Satapathy S, Sood A, Das CK, Mittal BR. Evolving role of 225Ac-PSMA radioligand therapy in metastatic castration-resistant prostate cancer-a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2021 Mar 21. doi: 10.1038/s41391-021-00349-w.
  99. Jain TK, Krishnaraju VS, Mittal BR, Sood A, Kumar R, Garg R, Kumar S. Follicular thyroid carcinoma with unusual radioiodine refractory breast metastasis mimicking primary breast malignancy. J Nucl Med Technol. 2021 Mar 15: jnmt.120.259259. doi: 10.2967/jnmt.120.259259. 
  100. Satapathy S, Das CK, Parihar AS, Sood A, Mittal BR. Response to Concomitant Enzalutamide and 177Lu-PSMA-617 Radioligand Therapy in ATM-Mutated Metastatic Castration Resistant Prostate Cancer. Clin Nucl Med. 2021 Jul 1;46(7):582-583.
  101. Behera S, Bawa M, Kanojia RP, Sood A, S Ram. Roux En Y drainage of a large hepatic hydatid cyst as treatment for recalcitrant bile leak: a case report. Ann Pediatr Surg 16, 43 (2020). https://doi.org/10.1186/s43159-020-00053-9.
  102. Mukherjee S, Arya AK, Bhadada SK, Saikia UN, Sood A, Dahiya D, Behera A. Parathyroid Carcinoma: An experience from 'Indian PHPT Registry'. Endocr Pract. 2021 Jan 27:S1530-891X(21)00020-3. doi: 10.1016/j.eprac.2021.01.014.
  103. Chowdhary AW, Kavanal AJ, Sood A, Prashar S, Upadhyay R, Bhattacharya A, Mittal BR. Posttraumatic Scab on 131I Whole-Body Scan-A False-Positive Finding. Clin Nucl Med. 2021 Jun 1;46(6):512-514.
  104. Venkata Subramanian Krishnaraju, Uma Nahar Saikia, Sanjay Kumar Bhadada, Bhagwant Rai Mittal, Ashwani Sood, Priyanka Singh, Divya Dahiya, Poonam Kumari. Cystic parathyroid adenomas: an enigmatic entity and role of Tc-99m sestamibi scintigraphy. Endocr Pract. 2021 Jun;27(6):614-620.
  105. Vijay Singh Gondil, Aarthi Chandrasekaran, Ashu Rastogi, Ashok Kumar Yadav, Ashwani Sood, Raja Ramachandran, Vivek Kumar, Manish Rathi, Harbir Singh Kohli, Vivekanand Jha, Krishan Lal Gupta. Proteinuria in severe hypothyroidism: A prospective study. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e749-e756.
  106. Ashwin Singh Parihar, Kunal Chandekar, Harpreet Singh, Ashwani Sood, Bhagwant Rai Mittal. Orbital and brain metastases on 68Ga-PSMA PET/CT in a patient with prostate carcinoma refractory to 177Lu-PSMA and 225Ac-PSMA therapy. Asia Ocean J Nucl Med Biol. 2021;9(1):67-70.
  107. Sarkar S, Ganesan R, Kumar B, Singh H, Basher R, Sood A. Intraoperative transesophageal echocardiography: A complement to 18F-fluorodeoxyglucose positron emission tomography-computed tomography in localizing pacemaker lead endocarditis. Ann Card Anaesth. 2020; 23:524-7.
  108. Satapathy S, Mittal BR, Sood A, Das CK, Singh SK, Mavuduru RS, Bora GS. Health-related quality-of-life outcomes with actinium-225-prostate specific membrane antigen-617 therapy in patients with heavily pretreated metastatic castration-resistant prostate cancer. Indian J Nucl Med 2020; 35:299-304.
  109. Raj Tigapuram KN, Gupta K, Sood A, Singla N, Rana N, Vatsa R, Ahuja CK, Mittal BR. Dynamic 18F-fluoro-ethyl-tyrosine positron emission tomography/computed tomography: A better predictor of isocitrate dehydrogenase mutation in presurgical evaluations of glioma. Indian J Nucl Med 2020;35:367-9.
  110. Shashank Shekhar Singh, Swathy Krishnan, Nitheeshraj K Tigapuram, Ashwani Sood,  Swayamjeet Satapathy, Manish Rohilla, Sindhu Tanigassalam, Bhagwant Rai Mittal. Axillary lymph nodal metastases from differentiated thyroid carcinoma: report of two cases with review of literature. J. Nucl. Med. Technol. 2021 Mar;49(1):89-91
  111. Satapathy S, Mittal BR, Sood A. Visceral Metastases as Predictors of Response and Survival Outcomes in Patients of Castration-Resistant Prostate Cancer Treated With 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy: A Systematic Review and Meta-analysis. Clin Nucl Med. 2020 Dec;45(12):935-942.
  112. Shelvin Kumar Vadi, Ashwani Sood, Prashant Panda, Uma Debi, Mohamed Yaser Arafath, Madan Parmar, Ajay Bahl, Bhagwant Rai Mittal. Reversible perfusion pattern in hypertrophied papillary muscles evident on myocardial perfusion imaging with CZT-based cardiac-specific camera. 2021 Feb;28(1):320-327.
  113. Arya AK, Kumari P, Bhadada SK, Agrawal K, Singh P, Mukherjee S, Sood A, Rao SD. Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry. J Bone Miner Metab.  2021 Mar;39(2):253-259.
  114. Kavanal AJ, Singh D, Sood A, Kumar SB, Satapathy S, Mittal BR Radioactive iodine therapy as single modality treatment in tumor thrombus arising from follicular thyroid carcinoma. J Nucl Med Technol. 2021 Mar;49(1):82-83.
  115. Prasad Reddy KV, Singhal M, Vijayvergiya R, Sood A, Khandelwal N. Diagn Role of DECT in coronary artery disease: a comparative study with ICA and SPECT. Interv Radiol. 2020 Sep;26(5):420-428.
  116. Agrawal K, Arya AK, Sood A, Kumari P, Singh P, Sapara M, Rastogi A, Behera A, Bhadada SK. A Detailed Appraisal of Renal manifestations in Primary Hyperparathyroidism from Indian PHPT Registry: Before and after curative parathyroidectomy. Clin Endocrinol (Oxf). 2021 Mar;94(3):371-376.
  117. Gawalkar AA, Bahl A, Ahluwalia J, Sood A, Sharma A, Sharma S, Dhir V. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus. A case-control study. Lupus. 2020 Oct;29(12):1503-1508.
  118. Ashwathanarayana AG, Singhal M, Satapathy S, Sood A, Mittal BR, Kumar RM, Parmar M, Krishnappa D, Rana N. 18F-NaF PET uptake characteristics of coronary artery culprit lesions in a cohort of patients of acute coronary syndrome with ST-elevation myocardial infarction and chronic stable angina: A hybrid fluoride PET/CTCA study. J Nucl Cardiol. 2020 Jul 27. doi: 10.1007/s12350-020-02284-0.
  119. Vikas K, Saurabh Mehrotra, Ashwani Sood, Yashpaul Sharma, Sildenafil Improves Right Ventricular Function, Exercise Capacity, and Quality of Life in Patients with Biventricular Dysfunction: Results from a Randomised Study. J. Cardiovasc Disease Res., 2020; 11(3): 85-89.
  120. Jain TK, Singh H, Kumar R, Bal A, Sood A, Mittal BR. Real Time F-18 FDG PET-CT-Guided Metabolic Biopsy Targeting Differential FDG Avidity in a Pulmonary Blastoma. Nucl Med Mol Imaging.  2020; 54:261-263.
  121. Bollampally N, Barwad P, Sood A, Parmar M, Dogra R, Mittal BR. Serendipitous detection of hiatus hernia due to stomach wall tracer uptake on (99m)Tc-MIBI myocardial perfusion imaging. J Nucl Cardiol. 2020 Jul 16. doi: 10.1007/s12350-020-02276-0.
  122. Rakesh Kapoor, Namrata Das, Raviteja Miriyala, Ashwani Sood, Arun Oinam, Navneet Singh. Challenges of radical chemoradiation planning in Stage III non-small-cell lung cancer: Can volumetric modulated arc radiotherapy overcome an unfavourable location? Physics and Imaging in Radiation Oncology.2020; 13:50-54
  123. Nazki S, Kanojia RP, Bawa M, Binu V, Lal S, Sood A, Samujh R. Robotic Excision of Choledochal Cyst with Hepaticoduodenostomy (HD): Report of HD Technique, Initial Experience, and Early Outcome. Eur J Pediatr Surg. 2021 Jun;31(3):286-291.
  124. Krishnaraju VS, Satapathy S, Sood A, Das CK, Chatterjee D, Shukla J, Mittal BR. Expression of CXCR4 Receptors in Refractory Atypical Mediastinal Carcinoid. Clin Nucl Med. 2020 Sep;45(9):e422-e424.
  125. Parihar AS, Dabas G, De D, Sood A, Jois AGA, Radotra BD, Mittal BR. Necrolytic Acral Erythema in Association With Hypothyroidism. JAMA Dermatol. 2020 Nov 1;156(11):1268-1270.
  126. Swayamjeet Satapathy , Bhagwant Rai Mittal, Ashwani Sood, Apurva Sood, Rakesh Kapoor, Rajesh Gupta. Peptide Receptor Radionuclide Therapy as First-Line Systemic Treatment in Advanced Inoperable/Metastatic Neuroendocrine Tumors. Clin Nucl Med. 2020 Sep;45(9):e393-e399.
  127. Parihar AS, Sood A, Sood A, Gulati A, Mittal BR. Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE post-therapy whole body scintigraphy. J Nucl Med Biol. 2020 Spring;8(2):132-135.
  128. Sood A, Mittal BR, Singh H. Duration of proton pump inhibitor abstinence before MPI. J Nucl Cardiol. 2020.  2020 Aug; 27(4):1415.
  129. Sharma A, Sood A. Mittal BR, Vijayvergia R. Assessment of myocardial viability using echocardiographic strain imaging in patients with ST-elevation myocardial infarction: comparison with cardiac PET imaging. J Echocardiogr. 2020 Dec;18(4):240-252.
  130. Satapathy S, Mittal BR, Sood A, Verma R, Panda N. Efficacy and safety of concomitant 177Lu-DOTATATE and low-dose capecitabine in advanced medullary thyroid carcinoma: a single-centre experience. Nucl Med Commun. 2020 Jul;41(7):629-635.
  131. Vatsa R, Sood A, Vadi SK, Das CK, Kaur K, Parmar M, Mittal BR. 225Ac-PSMA-617 Radioligand Posttherapy Imaging in Metastatic Castrate-Resistant Prostate Cancer Patient Using 3 Photopeaks. Clin Nucl Med. 2020 Jun;45(6):437-438.
  132. Pal R, Arya AK, Aggarwal A, Singh P, Dahiya D, Sood A, Singh T, Ram S, Bhansali A, Bhadada SK. Weight gain after curative parathyroidectomy predicts increase in bone mineral density in patients with symptomatic primary hyperparathyroidism. Clin Endocrinol (Oxf). 2020 Jul;93(1):28-35.
  133. Kavanal AJ, Bhadada SK, Sood A, Kaur G, Parwaiz A, Gulati A, Dahiya D, Mittal BR. Triple tracer positivity in metastatic lymph nodes from well-differentiated neuroendocrine tumor in MEN 1 syndrome. J Nucl Med Technol, 2020 Sep;48(3):287-289.
  134. Sood A, Gambhir S, Singh D, Kumar KU, Parihar AS, Kheruka S, et al. In-house-prepared semisolid bolus for esophageal transit scintigraphy in normal volunteers and its comparison with liquid bolus. Indian J Nucl Med. Apr-Jun 2020;35(2):130-135.
  135. Vadi SK, Bhattacharya A, Sood A, Mittal BR. Acute urinary obstruction during 99mTc-ethylenedicysteine diuretic renal scintigraphy acquisition: Is furosemide the culprit? World J Nucl Med. 2020;19:82-4.
  136. Zaidi A, Gautam U, Srinivasan R, Bal A, Prakash G, Sood A. Challenging diagnosis of two neoplasms, Langerhans Cell Histiocytosis and Papillary Thyroid Carcinoma from Fine Needle Aspiration of the thyroid by cell block immunocytochemistry and molecular testing for BRAFV600E mutation. Cytopathology. 2020 Nov;31(6):598-601
  137. Prashar S, Dahiya D, Sood A, Chatterjee D, Kaur R, Mittal BR. Revisiting 99mTc-MIBI Radioguided Surgery in Management of TENIS Syndrome. Clin Nucl Med. 2020 May;45(5):e243-e244.
  138. Bhadada SK, Pal R, Sood A, Dhiman V, Saini UC. Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy. Front Endocrinol (Lausanne). 2019 Nov 19;10:803. doi: 10.3389/fendo.2019.00803.
  139. Kumar R, Mittal BR, Bhattacharya A, Vadi SK, Singh H, Bal A, Shukla J, Singh H, Sharma V, Sood A, Singh SK. Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm. Diagn Interv Imaging. 2020 Mar;101(3):157-167.
  140. Malik D, Mittal BR, Sood A, Sharma A, Parmar M, Kaur K, Bahl A. Evaluation of left ventricular mechanical dyssynchrony with phase analysis in end-stage renal disease patients with normal gated SPECT-MPI. World J Nucl Med. 2019;18(3):238-243.
  141. Singh P, Kumar Vadi S, Nahar Saikia U, Sood A, Dahiya D, Arya AK, Behera A, Mukherjee S, Arvindkumar SM, Bhadada SK. Minimally invasive parathyroid carcinoma - a missing entity between parathyroid adenoma and carcinoma: scintigraphic and histological features. Clin Endocrinol (Oxf). 2019 Dec;91(6):842-850.
  142. Vadi SK, Panda P, Sood A, Bahl A, Debi U, Parmar M, Yaser M, Mittal BR. Reversible perfusion defect in hypertrophied papillary muscle on myocardial perfusion imaging: The 'filled doughnut sign'. J Nucl Cardiol. 2020 Jun;27(3):1056-1058.
  143. Konert T, Vogel WV, Paez D, Polo A, Fidarova E, Carvalho H, Duarte PS, Zuliani AC, Santos AO, Altuhhova D, Karusoo L, Kapoor R, Sood A, Khader J, Al-Ibraheem A, Numair Y, Abubaker S, Soydal C, Kütük T, Le TA, Canh NX, Bieu BQ, Ha LN, Belderbos JSA, MacManus MP, Thorwarth D, Hanna GG. Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial. Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2235-2243.
  144. Singh H, Mittal BR, Sood A, Bollampally N, Gorla AKR, Dasagrandhi V, Parmar M. Association of use of proton pump inhibitors and H2 antagonists with stomach wall uptake in 99mTc-methoxy-isobutyl-isonitrile (MIBI) myocardial perfusion imaging. J Nucl Cardiol. 2020 Oct;27(5):1611-1619.
  145. Thanseer NTK, Parihar AS, Sood A, Bhadada SK, Dahiya D, Singh P, Mittal BR. Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity. World J Nucl Med. 2019 Apr-Jun;18(2):198-200.
  146. Pal R, Bhadada SK, Shingare A, Bhansali A, Kamalanathan S, Chadha M, Chauhan P, Sood A, Dhiman V, Sharma DC, Saikia U, Chatterjee D, Agashe V. Tumor-induced osteomalacia: experience from three tertiary care centres In India. Endocr Connect. 2019 Mar;8(3):266-276.
  147. Sood A, Singh D, Dutta U, Mittal BR, Parmar M, Kaur G, Kaur K. Effect of ursodeoxycholic acid in facilitating early hepatic clearance of radiotracer among patients undergoing 99mTc-sestamibi myocardial perfusion scintigraphy: A randomized double blind placebo controlled parallel trial. J Nucl Cardiol. 2020 Dec;27(6):2337-2348.
  148. Malik D, Sood A, Mittal BR, Basher RK, Bhattacharya A, Singh G. Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in restaging and prognosis of recurrent melanoma after curative surgery. World J Nucl Med. 2019 Apr-Jun;18(2):176-182.
  149. Jain TK, Sood A, Sood A, Basher RK, Prakash G, Prakash M, Mittal BR. Utility of F-18 Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Patient Presenting with Acute Paraparesis in Detecting Isolated Relapse of Non-Hodgkin's Lymphoma Infiltrating the Spinal Cord. Indian J Nucl Med. 2019 Apr-Jun;34(2):178-179.
  150. Sharma A, Vadi SK, Sood A, Mete UK, Kakkar N, Vashishta RK, Mittal BR. Rare Presentation of Metastatic Endometrioid Adenocarcinoma of Uterus Mimicking as Second Primary in Urinary Bladder on 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography. Indian J Nucl Med. 2019 Apr-Jun;34(2):169-170.
  151. Arora Y, Singh RS, Sampath S, Sood A, Singh P, Singh H, Mishra AK, Parmar M. Impact of hibernating and viable myocardium on improvement in perfusion and left ventricular ejection fraction after coronary artery bypass graft. Nucl Med Commun. 2019;40:325-332.
  152. Arya AK, Bhadada SK, Mukherjee S, Singh P, Rana SS, Dahiya D, Sood A, Saikia UN, Prakash M, Bhasin DK, Behera A, Walia R, Bhansali A. Frequency & predictors of pancreatitis in symptomatic primary hyperparathyroidism. Indian J Med Res. 2018 Dec;148(6):721-727
  153. Gupta V, Moond V, Irrinki S, Sood A, Gulati A, Bal A, Vaiphei K, Sinha SK, Kochhar R. Middle Preserving Pancreatectomy: A Viable Option for Parenchyma Preserving Pancreatic Resection. JOP. J Pancreas (Online) 2018 Jul 30; 19(4):164-170.
  154. Vadi SK, Mehrotra S, Sood A, Parmar M, Dasagrandhi V, Kaur K, Mittal BR. Flip-flop right ventricle myocardial perfusion on stress-rest 99mTc-MIBI myocardial perfusion scintigraphy: An indirect evidence for severe left ventricular coronary arterial disease? J Nucl Cardiol. 2019 Jun;26(3):1033-1035.
  155. Vadi SK, Rajan P, Sood A, Rohit MK, Parmar M, Kaur K, Mittal BR. Stress-induced ischemia in the right ventricular myocardium on 99mTc-MIBI myocardial perfusion scintigraphy in a rare case of double-chambered right ventricle. J Nucl Cardiol. 2019 Dec;26(6):2148-2150.
  156. Singh D, Lal SB, Sood A, Gupta R, Kumar R, Vashishta RK, Mittal BR. Management of Primary Lymph Nodal Gastrinoma With Liver Metastases Resulting in Zollinger-Ellison Syndrome. Clin Nucl Med. 2019 Jan;44(1):e36-e39.
  157. Kumar G, Khadwal A, Sood A, Singh H, Dasagrandhi V, Kashyap S, Mittal BR. What is this image? 2018: Image 3 result: Extramedullary hematopoiesis at unusual site detected with 99mTc-labeled RBC imaging and 18F-FLT PET/CT. J Nucl Cardiol. 2018 Dec;25(6):1903-1905.
  158. Vadi SK, Mittal BR, Sood A, Singh G, Bal A, Parihar AS, Bhattacharya A, Basher RK, Kapoor R. Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer. Nucl Med Commun. 2019 Jan;40(1):63-72.
  159. Mukherjee S, Bhadada SK, Arya AK, Singh P, Sood A, Dahiya D, Ram S, Saikia UN, Behera A. Primary hyperparathyroidism in the young: comparison with the adult primary hyperparathyroidism. Endocr Pract. 2018 Dec;24(12):1051-1056.
  160. Malik D, Mittal BR, Sood A, Parmar M, Kaur K, Bahl A. Prognostic value of left ventricular mechanical dyssynchrony indices in long-standing type II diabetes mellitus with normal perfusion and left ventricular systolic functions on SPECT-MPI. J Nucl Cardiol. 2020 Oct;27(5):1640-1648.
  161. Kumar R, Mittal BR, Bhattacharya A, Singh H, Bal A, Vadi SK, Sood A, Prakash G, Singh H, Sharma A. Diagnostic performance of real-time robotic arm-assisted 18F-FDG PET/CT-guided percutaneous biopsy in metabolically active abdominal and pelvic lesions. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):838-847.
  162. Sood A, Parihar AS, Sood A, Kumar R, Prakash G, Singhal M, Gulati A, Mittal BR, Bahl A, Singh S. Unusual Presentation of Hurthle Cell Carcinoma With TENIS Syndrome as Left Atrial Thrombus on 18F-FDG PET/CT. Clin Nucl Med. 2018 Oct;43(10):e352-e354.
  163. Kavanal AJ, Singh D, Sood A, Parmar M, Mittal BR. Phenytoin Could Potentially Increase Hepatic Clearance of 99mTc-Sestamibi in Myocardial Perfusion Imaging. Clin Nucl Med. 2018 Sep;43(9):e341-e342.
  164. Vadi SK, Kashyap S, Sood A, Khadwal A, Parmar M, Parihar AS, Mittal BR. Can 99mTc-labeled RBC-equilibrium radionuclide angiocardiography be an adjunct imaging biomarker for marrow hyperplasia in beta-thalassemia major patients? J Nucl Cardiol. 2019 Aug;26(4):1380-1382.
  165. Sharma A, Vadi SK, Sood A, Kumar S, Mete UK, Parkhi M, Mittal BR. Bladder Leiomyoma: A Rare Differential and a Potential Pitfall in the Evaluation for a Bladder Mass in 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography. Indian J Nucl Med. 2018 Jul-Sep; 33(3):264-265.
  166. Parihar AS, Sood A, Kumar R, Bhusari P, Shukla J, Mittal BR. Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1836-1837.
  167. Malik D, Kumar R, Mittal BR, Singh H, Bhattacharya A, Sood A, Sharma V, Singh H. 68Ga-labelled (prostate specific membrane antigen) expression in signet-ring cell gastric carcinoma. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1276-1277.
  168. Parihar AS, Sood A, Lukose TT, Seam RK, Mittal BR. Metabolic Bone Superscan in Carcinoma Breast with Occult Graves’ disease: Looking Beyond Skeletal Metastases. Indian J Nucl Med. 2018 Apr-Jun; 33(2):145-147.
  169. Parihar AS, GA A, Sood K, Seam RK, Kaushal V, Sood A, Kakkar N, Mittal BR. Incidental Detection of Synchronous Lung Melanoma on 18F-FDG PET/CT in a Patient with Parotid Gland Myoepithelial Carcinoma. Clin Nucl Med. 2018; 43(4):e127-e129.
  170. Malik D, Sood A, Parmar M, Mittal BR. Comparison of Left Ventricular Phase Parameters Analysis between Two Software Programs in Patients with Normal Gated Single-photon Emission Computed Tomography-Myocardial Perfusion Imaging. Indian J Nucl Med. 2018;33(1):14-19
  171. Khanal S, Rao RG, Sood A, Dutta P. Effective early screening modalities for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. J Cardiovasc Disease Res. 2018; 9 (2):121-125.
  172. Jain TK, Basher RK, Sood A, Ashwathanarayana AG, Parihar AS, Mittal BR. Cerebral Hemisphere Hypoperfusion with Ipsilateral Internal Jugular Vein and Upper Extremity Deep Vein Thrombosis in Lung Carcinoma on 18F-Fluorodeoxyglucose Positron Emission Tomography/Contrast-enhanced Computed Tomography. Indian J Nucl Med. 2018; 33(1):88-89.
  173. Vadi SK, Singh D, Sood A, Bahl A, Parmar M, Mittal, BR. Role of Tc-99m sestamibi SPECT/CT myocardial perfusion imaging in management of spontaneous coronary artery dissection: A case report. IHJ Cardiovascular Case Reports. 2018; (2):20-23.
  174. Thanseer NTK, Bhadada SK, Sood A, Parihar AS, Dahiya D, Singh P, Basher RK, Das A, Mittal BR. Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid
    Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT. Nucl Med Mol Imaging.  2018 Apr;52(2):154-158.DOI 10.1007/s13139-017-0488-3.
  175. Malik D, Mittal B, Sood A, Parmar M, Kaur G, Bahl A. Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI. J Nucl Cardiol. 2019 Oct;26(5):1650-1658.
  176. Vadi SK, Mittal BR, Gorla AKR, Sood A, Basher RK, Sood A, Kakkar N, Sen RK.18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients with Suspected Recurrence of Chondrosarcoma. Clin Nucl Med. 2018; 43(2):87-93.
  177. Jain TK, Parihar AS, Sood A, Basher RK, Bollampally N, Shekhawat AS, Mittal BR. Orbital Metastasis: Rare Initial Presentation of an Occult Gall Bladder Carcinoma. Clin Nucl Med. 2018 Mar;43(3):188-189.
  178. Radhakrishnan RK, Mittal BR, Gorla AKR, Basher RK, Sood A, Bal A, Kalra N, Khandelwal N, Singh N, Behera D. Real time intra-procedural 18F-FDG PET/CT guided biopsy using automated robotic biopsy arm (ARA) in the evaluation of thoracic lesions with prior inconclusive biopsy results: initial experience from a tertiary health centre. Br J Radiol. 2017 Dec;90(1080):20170258
  179. Paudel J, Singh H, Sood A, Bhattacharya A, Mittal BR. Serendipitous detection of extraosseous metastases on bone scintigraphy: Utility of cross sectional and correlative imaging. World J Nucl Med. 2017 Oct-Dec;16(4):331-333.
  180. Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, Kalathoorakathu RR, Singh P, Dahiya D, Saikia UN, Rao SD. Comparative effectiveness of ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med. 2017 Dec; 42(12):e491-e497.
  181. Ashwathanarayana AG, Biswal CK, Sood A, Parihar AS, Kapoor R, Mittal BR. Image guided combination of 177Lu-DOTATATE and capecitabine peptide receptor chemoradionuclide therapy in metastatic mediastinal paraganglioma. J Nucl Med Technol. 2017; 45; 314-316.
  182. Radhakrishnan RK, Gorla AKR, Sood A, Prakash M, Bhattacharya A, Mittal BR. Utility of Three-phase Skeletal Scintigraphy with Single Photon Emission Computed Tomography/Computed Tomography in a Case of Chronic Recurrent Multifocal Osteomyelitis. Indian J Nucl Med. 2017 Jul-Sep; 32(3):251-253.
  183. Sood A, Singh H, Sood A, Basher RK, Mittal BR. Incidentally Detected Thyroid Follicular Neoplasm on Somatostatin Receptor Imaging and Post-therapy Scan. Indian J Nucl Med. 2017 Jul-Sep;32(3):224-226.
  184. Parghane RV, Sood A, Vaiphei K, Aggarwal AN, Mittal BR. Presentation of Unusual Tracheal Metastasis on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography after 9 Years in Postnephrectomy Patient of Renal Cell Carcinoma: A Case Report and Review of Literature. World J Nucl Med. 2017 Jul-Sep; 16(3):240-242.
  185. Padinhare-Keloth TNTK, Bhadada SK, Sood A, Kumar R, Behera A, Radotra BD, Mittal BR. Sensitive Detection of a Small Parathyroid Adenoma Using Fluorocholine PET/CT: A Case Report. Nucl Med Mol Imaging. 2017 Jun;51(2):186-189.
  186. Rayamajhi SJ, Gorla AKR, Basher RK, Sood A, Mittal BR. Unsuspected Active Ulcerative Colitis in a Patient with Dermatomyositis: A Rare Association Detected on 18F-FDG PET/CT during the Search for an Occult Malignancy. Indian J Nucl Med. 2017 Apr-Jun;32(2):130-132.
  187. Vadi SK, Singh B, Basher RK, Watts A, Sood AK, Lal A, Kakkar N, Singh SK. 18F-fluorocholine PET/CT complementing the role of dynamic contrast-enhanced MRI for providing comprehensive diagnostic workup in prostate cancer patients with suspected relapse following radical prostatectomy. Clin Nucl Med.2017 Aug; 42(8):e355-e361
  188. Jain TK, Basher RK, Sood A, Mittal BR, Prakash G, Bhatia A. 18F-FDG PET/CT Finding of Drop Metastases from Germ Cell Tumor of Pineal Gland. J Nucl Med Technol. 2017 Jun; 45 (2):114-115.
  189. Jain T, Thanseer NT, Sood A, Parmar M, Bhattacharya A, Mittal B. Scintigraphic findings in end-stage liver disease on Tc-99m sestamibi SPECT/CT myocardial perfusion imaging. J Nucl Cardiol. 2018 Jun;25(3):1051-1052.
  190. Bhadada SK, Dhiman V, Mukherjee S, Aggarwal S, Bal A, Sukumar SP, Sood A, Sharma DC, Khandelwal N, Bhansali A, Van Hul W, Rao SD. Fibrogenesis Imperfecta Ossium and Response to Human Growth Hormone: A Potential Novel Therapy. J Clin Endocrinol Metab. 2017 May 1; 102(5):1750-1756.
  191. Jain TK, Singh SK, Sood A, Ashwathanarayama AG, Basher RK, Shukla J, Mittal BR. A rare adult renal neuroblastoma better imaged by 18F-FDG than by 68Ga-dotanoc in the PET/CT scan. Hell J Nucl Med. 2017 Mar 20 (1):100-101.
  192. Deepa Singh, Shelvin K. Vadi, Madan Parmar, Ashwani Sood, Saurabh Mehrotra, Bhagwant R. Mittal. Role of 99mTc-sestamibi gated SPECT/CT myocardial perfusion imaging in the management of patients with myocardial bridging and its correlation with coronary angiography. J Cardiology Cases April 2017 15(4): 136-140.
  193. Sharma A, Mete UK, Sood A, Kakkar N, Gorla AK, Mittal BR. Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumor grade and T-stage of urinary bladder carcinoma: Results from a prospective single center study. Br J Radiol. 2017 Apr;90(1072)
  194. Jayanthi MR, Sasikumar A, Gorla AK, Sood A, Bhattacharya A, Mittal BR. Adenosine Stress Induced Left Bundle Branch Block During Technetium-99m Tetrofosmin Myocardial Perfusion Imaging. World J Nucl Med. 2017 Jan-Mar; 16(1):78-80.
  195. Santosh K, Dhir V, Singh S, Sood A, Gupta A, Sharma A, Sharma S. Prevalence of secondary Sjögren's syndrome in Indian patients with rheumatoid arthritis: a single-center study. Int J Rheum Dis. 2017 Jul; 20(7):870-874.
  196. Sood A, Parihar AS, Thapa BR, Kanojia RP, Mittal BR, Bhattacharya A. Hepatobiliary Scintigraphy Findings Lead to the Diagnosis of Spontaneous Common Bile Duct Rupture in an Infant. Clin Nucl Med. 2017 Mar; 42(3):223-224.
  197. Vadi SK, Chouhan DK, Gorla AKR, Shukla J, Sood A, Mittal BR. Potential Adjunctive Role of Radiosynovectomy in Primary Synovial Osteochondromatosis of the Knee: A Case Report. Nucl Med Mol Imaging. 2017 Sep;51(3):252-255.
  198. Jain T, Khadwal A, Sood A, Kalathoorakath R, Parmar M, Mittal B. Bone marrow hyperplasia detected by gated blood pool imaging. J Nucl Cardiol. 2017 Apr;24(2):739-741.
  199. Malik D, Sood A, Parmar M, Sood A, Radotra B, Mittal B. Incidental detection of bronchial carcinoid on Tc-99m sestamibi SPECT/CT myocardial perfusion scintigraphy. J Nucl Cardiol. 2017; 24:319–22.
  200. Roshan Verma, Sourabha Kumar Patro, Niveditha Damodharan, Ashwani Sood, Amanjit Bal. Papillary carcinoma thyroid in a thyroglossal cyst: a management dilemma. Acta Oto-Laryngica case Reports, 2:1,5-10, DOI: 10.1080/23772484.2016.120166.
  201. Sood A, Sharma A, Chouhan DK, Gupta K, Parghane R, Shukla J, Mittal BR. Failed Radiation Synovectomy in Diseased Knee Joint with Missed Tuberculous Synovitis. World J Nucl Med. 2016 Sep; 15(3):206-8.
  202. Malik D, Sood A, Parmar M, Bahl A, Sood A. Unexpected detection of pericardial effusion on myocardial perfusion scintigraphy. Indian J Nucl Med. 2016;31:317-318
  203. Gorla AK, Sood A, Mittal BR. Role of choline PET/CT in evaluation of primary and secondary hyperparathyroidism. Nucl Med Commun. 2016 Jun; 37(6):672.
  204. Kalathoorakath RR, Sharma A, Sood A, Nahar U, Gorla AKR, Mittal BR. 18F-FDG PET/CT imaging and PET-guided biopsy in evaluation and treatment decision in adrenal histoplasmosis. BJR Case Report. 2016 Jul 28;2(3):20150451
  205. Gorla AK, Gupta K, Sood A, Biswal CK, Bhansali A, Mittal BR. Adrenal tuberculosis masquerading as disseminated malignancy: A pitfall of 18F-FDG PET/CT Imaging. Rev Esp Med Nucl Imagen Mol. 2016 Jul-Aug;35(4):257-9
  206. Phulsunga RK, Parghane RV, Kanojia RK, Gochhait D, Sood A, Bhattacharya A, Mittal BR. Multiple Brown Tumors Caused by a Parathyroid Adenoma Mimicking Metastatic Bone Disease from Giant Cell Tumor. World J Nucl Med. 2016 Jan-Apr; 15(1):56-8.
  207. Gorla AK, Sood A, Prakash G, Parmar M, Mittal BR. Substantial Increase in Myocardial FDG Uptake on Interim PET/CT May Be an Early Sign of Adriamycin-Induced Cardiotoxicity. Clin Nucl Med. 2016; 41:462-3.
  208. Jain TK, Phulsunga RK, Sood A, Bhattacharya, Mittal BR. Diagnostic uncertainty of isolated skull lesion in prostate cancer: Role of SPECT/CT. Iran J Nucl Med 2016;24 (1):72-75
  209. Jain TK, Kumar S, Sood A, Bhattacharya A, Mittal BR. Dual thyroid ectopia - role of thyroid scintigraphy and neck ultrasonography. Indian J Nucl Med 2015; 30:338-40.
  210. Jain TK, Phulsunga RK, Kumar S, Sood A, Bhattacharya A, Mittal BR. Lung or liver: An imaging dilemma on Tc-99m macroaggregated albumin lung perfusion scintigraphy. Indian J Nucl Med. 2015 Oct-Dec;30(4):362-3.
  211. Jain TK, Phulsunga RK, Gupta N, Sood A, Bhattacharya A, Mittal BR. Vicarious liver visualization in solitary functioning kidney with technetium-99m ethylene dicysteine renal scintigraphy. Indian J Nucl Med. 2015 Jul-Sept; 30 (3):272-4.
  212. Nada R, Gupta A, Kang M, Rawat A, Sood A, Ahluwalia J, Singh S. Hepatic mass and coagulopathy in a 10 years boy with fever. Arthritis Rheumatol. 2015 Jul;67(7):1977
  213. Trehan R, Seam RK, Gupta MK, Sood A, Dimri K, Mahajan R. Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancer. World J Nucl Med. 2014 Sep; 13(3):163-9.
  214. Jung RS, Parghane RV, Sood A, Bhattacharya A, Mittal BR. Primary autoimmune thrombocytopenia and co-existing Graves' disease: Role of radioiodine-131.Indian J Nucl Med. 2014 Jul;29(3):195-6
  215. Reddy Gorla AK, Agrawal K, Sood A, Bhattacharya A, Mittal BR. Differential uptake of Tc-99m DMSA and Tc-99m EC in renal tubular disorders: Report of two cases and review of the literature. Indian J Nucl Med. 2014 Jul;29(3):160-2
  216. Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in Localization of Tumor Causing Oncogenic Osteomalacia. Clin Nucl Med. 2015 Jan;40(1):e6-e10.
  217. Jung RS, Mittal BR, Santhosh S, Sood A, Bhattacharya A, Kapoor R. Is femoral uptake of Tc99m-methylene diphosphonate on bone scintigraphy in bronchogenic carcinoma an alarming sign: A case report and brief review of literature? Lung India. 2014 Jul; 31(3):280-1.
  218. Bhoil A, Gayana S, Sood A, Bhattacharya A, Mittal BR. Hybrid single photon emission computed tomography/computed tomography sulphur colloid scintigraphy in focal nodular hyperplasia. World J Nucl Med. 2013 Sep;12(3):124-5.
  219. Revannasiddaiah S, Sood A, Kumar S, Thakur P. Cervical nodal metastasis in head and neck cancer: a clinical conundrum. BMJ Case Rep. 2013 Nov 6;2013.
  220. Sushmita Ghoshal, Tapesh Bhattacharyya, Ashwani Sood, Ruchita Tyagi. Palliative Radiation in Primary Squamous Cell Carcinoma of Thyroid: A Rare Case Report Indian J Palliat Care. 2013; 19(3):192-4
  221. Rayamajhi Sampanna Jung, Kanhaiyalal Agarwal, Ashwani Sood, Anish Bhattacharya, Bhagwant Rai Mittal. Hybrid SPECT/CT as a diagnostic modality in suspected urinoma with ambiguous planar Tc99mEC renal Scintigraphy. Indian J Nucl Med. 2013; 28(4):254-5.
  222. Sood A, Agarwal K, Shukla J, Goel R, Dhir V, Bhattacharya, Mittal BR. Bone scintigraphic patterns in patients of tumor induced osteomalacia. Indian J Nucl Med. 2013; 28(3):173-5.
  223. J Mohanroop, Kanahaiyalal Agrawal, Ashwani Sood, Anish Bhattacharya, Bhagwant R Mittal. The use of SPET-CT and Tc99m sulphur colloid to image peritoneo-pleuric shunt and thoracic duct in a patient with liver insufficiency and ascites. Hell J Nucl Med. 2013 Sep-Dec; 16(3):242.
  224. Mohan JR, Santhosh S, Sood A, Bhattacharya A, Mittal BR. Pertechnetate thyroid scan in Marine-Lenhart syndrome. Indian J Nucl Med. 2013; 28(2):125-6.
  225. Sampath S, Mittal BR, Arun S, Sood A, Bhattacharya A, Sharma A. Usefulness of asymmetry score on quantitative three-phase bone scintigraphy in the evaluation of complex regional pain syndrome. Indian J Nucl Med. 2013; 28:11-6.
  226. Arun S, Santhosh S, Sood A, Bhattacharya A, Mittal BR. Added value of SPECT/CT over planar Tc-99m mebrofenin hepatobiliary scintigraphy in the evaluation of bile leaks. Nucl Med Commun. 2013; 34:459-66.
  227. Jaya Shukla, BR Mittal, A Sood, GP Bandopadhaya. CaCO3 microparticle containing ibandronate-alginate beads for improved adherence to bisphosphonate oral therapy: formulation and in-vitro release. Int J Pharm 2013; 3(2): 340-347.
  228. Bhagwant Rai Mittal, Kanhaiyalal Agrawal, Jaya Shukla, Anish Bhattacharya, Baljinder Singh, Ashwani Sood, Anil Bhansali. Ga-68 DOTATATE PET/CT in Neuroendocrine Tumors: Initial Experience J Postgrad Med Edu Res 2013; 47 (1): 74-6.
  229. Revannasiddaiah S, Sood A, Thakur P, Sharma M. Skeletal metastases from renal cell carcinoma: Diagnostic uncertainty with molecular imaging. BMJ Case Rep. 2012 Aug 24; 2012. doi: pii: bcr0220125910. 10.1136/bcr.02.2012.5910. PMID:22922912
  230. Revannasiddaiah S, Rastogi M, Thakur P, Gupta MK, Sood A, Sharma C. MRI for the detection of prostate cancer origin vertebral metastases in the preosteoblastic phase. BMJ Case Rep. 2012 Jul 9; 2012. doi:pii: bcr2012006265. 10.1136/bcr-2012-006265. PMID:22778472
  231. Arun S, Sood A, Bhattacharya A, Mittal BR. Incidental detection of axillary lymph node metastasis from carcinoma breast during technetium-99m methoxyisobutyl-isonitrile parathyroid scintigraphy Indian J Nucl Med. 2012; 27(2) :133-4.
  232. Santhosh S, Mittal BR, Arun S, Sood A, Bhattacharya A, Kochhar R. Quantitative cholescintigraphy with fatty meal in the diagnosis of Sphincter of Oddi dysfunction and acalculous cholecystopathy. Ind J Gastroenterol. 2012, 31(4):186-190.
  233. Sood A, Seam RK, Mardi K, Gupta MK, Sethi S. Prediction of lack of response to neoadjuvant chemotherapy in rare breast tumour histology with Tc-99m sestamibi scintimammography. Ann Nucl Med. 2011, 25:524–527
  234. A Sood, RK Seam, M Gupta, Dev R Sharma, P Bhardwaj. Dual Ectopic Thyroid: A Case Report with Review of Literature Iran J Radiol 2011,8(1):29-32.
  235. Sood A, Revannasiddaiah S, Kumar R. Nuclear medicine in myeloma: the state of the science and emerging trends. Hell J Nucl Med. 2011 Jan-Apr; 14(1):2-5.
  236. Sood A, Sethi S, Kumar R. Tracheal uptake on Tc-99m MDP bone scintigraphy can be a potential source of false-positive results in a prostate cancer patient. Clin Nucl Med. 2010 Jun;35(6):454-5
  237. Kumar R, Lal N, Dhanapathi H, Lal H, Malhotra A, Sood A. Tc-99m-dimercaptosuccinic acid and Tc-99m diethylenetriamine pentaacetic acid renal scan detect "reverse horseshoe kidney". Clin Nucl Med. 2010 May;35(5):338-40.
  238. Sood A, Seam RK, Sethi S, Gupta M. Diffuse hepatic and splenic Tc-99m MDP tracer uptake in case of multiple myeloma. Ind J Nucl Med. 2010 Apr; 25(2):70-2.
  239. Sood A, Raman R, Jhobta A, Dhiman DS, Seam RK. Normal technetium-99m-MDP uptake in fibrous dysplasia of the hip. Hell J Nucl Med. 2009 Jan-Apr; 12(1):72-3.
  240. Sood A, Kumar R. The ectopic thyroid gland and the role of nuclear medicine techniques in its diagnosis and management. Hell J Nucl Med. 2008 Sep-Dec; 11(3):168-71.
  241. Sood A, Sood V, Sharma DR, Seam RK, Kumar R, Thyroid scintigraphy in detecting dual thyroid ectopy: A review. Eur J Nucl Med & Mol Imaging, 2008 April 35 (4): 843-6
  242. A Sood, RK Seam, V Sood, R Kumar. Two artifacts in the 131Ι whole body post treatment scan of in a thyroid cancer patient. Hell J Nucl Med, 2007 Sep-Dec;10(3):184
  243. Sood A. Role of radioiodine therapy in differentiated thyroid cancer. Radiation Oncology 2007;7(2):91-96
  244. Verma DK, Sood A, Seam RK, Gupta MK, Gupta S, Negi SC, Primary papillary carcinoma arising in a thyroglossal cyst- A case report. Ind J of Medical & Paediatric Oncology 2006; 27 (2):31-33.
  245. Sood A, Gambhir S, Sewatkar AB, Deswal S, Sarswat V.A, Kumar R, Esophageal Motor Disorder diagnosed by Esophageal Transit Scintigraphy. Clin Nucl Med Nov 2004; 29(11): 768-769.
  246. Sood A, Youssef IM, Heiba SI, El Zeftawy HM, Axelrod D, Seigel B, Mills C, Abdel-Dayem HM, Alternative Lymphatic Pathway Following Previous Axillary Node Dissection in Recurrent / Primary Breast Cancer. Clin Nucl Med Nov 2004; 29(11): 698-702.
  247. Sood A, Senthilnathan MS, Deswal S, Pradhan PK, Das BK, Kumar R, Spontaneous Rupture of a Choledochal Cyst and the Role of Hepatobiliary Scintigraphy. Clin Nucl Med. Jun 2004; 29(6): 392-393.
  248. Gambhir S, Sood A, Sethi RS, Deswal S, Kheruka SC, Das BK, Kar DK, Aggarwal G, Significance of Early Static Views Acquired during Parathyroid Imaging with Tc-99m MIBI- A Case Report, Ind J Nucl Med 2000 Vol 15 No.2 pp83-84.Abstracts (International & National) ~100

Memberships:

  1. Life Member of Society of Nuclear Medicine, India (SNMI)
  2. Life Member of Society of Nuclear Medicine, India, Northern Chapter (SNM-NC)
  3. Life Member of Nuclear Cardiological Society of India (NCSI)
  4. Life Member of Indian Society of Bone Metabolism and Research (ISBMR)
  5. Member of American Society of Clinical Oncology (ASCO) USA
  6. Member of National Academy of Medical Sciences, India (MNAMS)
  7. Member of Society of Nuclear Medicine and Molecular Imaging (SNMMI) USA
  8. Fellow of International Union against Cancer (UICC), Switzerland
  9. Member of Indian College of Nuclear Medicine (MICNM)
  10. Fellow of Indian College of Nuclear Medicine (FICNM)

Conferences, Workshops Attended \Papers Presented:

  1. Cancer Update, Shimla, June 1995
  2. WHO Seminar on Chemical Carcinogenesis, Shimla, November 1995.
  3. CME cum National Update in Cardiology, Shimla, November 1995.
  4. Workshop on Nuclear Medicine in Nephro-Urology, Vellore, March 1996.
  5. National Workshop on Quality Assurance in Nuclear Medicine Instrumentation, New Delhi, October 1996.
  6. 4th Annual Conference of North Zone, AROI, Shimla, October 1997
  7. 29th Annual Conference of SNM India & Symposium by Indo-American Society of Nuclear Medicine, Chandigarh, November 1997.
  8. Symposium on Peadiatric Nuclear Medicine, New Delhi, March 1998.
  9. IX International Medical Science Academy Conference (IMSACON), Shimla, May 1998
  10. 2nd Annual Conference of Nuclear Cardiological Society of India, New Delhi, Nov 1999.
  11. Regional (RCA) Training Workshop (IAEA) in Myocardium Perfusion Scintigraphy using SPECT for Nuclear Medicine Physician, New Delhi, December, 2000.
  12. National Symposium on Statistical and Mathematical Techniques & Radiation Safety in Nuclear Medicine, New Delhi, Februry, 2001.
  13. 3rd National Conference of Nuclear Cardiology, Hyderabad, December 2001.
  14. Symposium on Nuclear Medicine in Oncology, Chandigarh, October 2002.
  15. 34th Annual Conference of SNM India & Symposium by Indo-American Society of Nuclear Medicine, Kolkata, December 2002.
  16. Presented paper on “Significance of Lymphoscintigraphy & Localization of Sentinel Node in Early Breast Cancer” at CME cum 7th National Meeting on Breast Cancer, Shimla, March 2003
  17. Presented oral paper on “Semisolid Jelly Esophageal Transit Scintigraphy in patients of Esophageal Motor Disorders” at 43rd Annual Congress Of Japanese Society of Nuclear Medicine, Tokyo, Japan 27th- 29th October 2003
  18. 35th Annual Conference of SNM India & Symposium by Indo-American Society of Nuclear Medicine, Bhopal, December 2003.
  19. Lecture delivered on Radioactive Iodine in Thyrotoxicosis-experience in Shimla, 6th Annual Conference of Association of Physician of India (API)-Himachal Chapter, Mandi, October 2004
  20. Presented oral paper on “Esophageal Transit Scintigraphy in healthy volunteers using 99mTc- labeled sulphur colloid semisolid jelly” at 8th Asia & Oceania Congress of Nuclear Medicine & Biology, Beijing, China 9th –13th October 2004
  21. 3rd Annual Conference of Association of Nuclear Medicine Physicians of India, Srinagar, Sept-Oct.2005
  22. XIth Annual Conference of North Zone of Association of Radiation Oncologist of India, Shimla, Oct.2005
  23. 5th Biennial Conference of Nuclear Cardiological Society of India, Chandigarh, Oct.2005
  24. CME on Positron Emission Tomography (PET-CT), New Delhi, Feb 2006
  25. 25. International Symposium on Advances in Diagnostic Medical Physics & Workshop on Cyclotron - PET/CT, New Delhi, July 2006
  26. 26. Lecture delivered on “Scintigraphy in bone lesions” 2nd Chapter North Zone-IRIA, HP, State Branch, Shimla Conference cum CME, October 2006
  27. 27. 39th Annual Conference of Society of Nuclear Medicine, India & Nuclear Cardiological Society of India, Lucknow Dec2007
  28. 28. 9th Asia-Oceania Conference of Nuclear Medicine & Biology, New Delhi, Oct-Nov2008
  29. 29. 42nd Annual Conference of Society of Nuclear Medicine, India & Nuclear Cardiological Society of India, Chandigarh Nov 2010
  30. 30. Delivered lecture as invited guest “32nd Annual Conference of Indian Association of Bio- Medical Scientists” Chandigarh Nov 2011
  31. 31. Poster presentation in International Conference on Integrated Medical Imaging in Cardiovascular Disease (IMIC 2013) organized by IAEA, Vienna, Austria Oct 2013
  32. 32. Chaired sessions in IX the Biennial Nuclear Cardiological Society of India at Chennai Oct 2013
  33. 33. Delivered lecture as invited speaker on CME “Medical Cyclotron and PET Imaging: Needs and Challenges” at SGPGI, Lucknow April 2014
  34. 34. Delivered lecture as invited speaker on CME-2014 “Therapeutic Applications of “ Radioisotope” at SKIMS, Srinagar May 2014
  35. 35. Attended First Research Coordination Meeting of IAEA “PET/CT based Radiotherapy Planning in NSCLC” at Vienna, Austria July 2014
  36. 36. Poster presentation in 27th Annual Congress of the European Association of Nuclear Medicine-EANM’14 at Gothenburg, Sweden Oct 2014
  37. 37. Attended Regional Training Course (IAEA) on “Essentials of Hybrid Nuclear Medicine Imaging” at Chiangmai, Thailand Dec 2014
  38. Attended PGIMER Research Methodology Workshop, 2015 at PGIMER, Chandigarh Feb 2015
  39. Delivered lecture as invited speaker-10th Biennial Conference of Nuclear Cardiological Society of India, at SGPGI, Lucknow Oct 2015
  40. Poster presentation in International Conference on IPET 2015 organized by IAEA, Vienna, Austria Oct 2015
  41. Delivered lecture as invited speaker – North Zone, Association of Orthopedics, India, at Chandigarh Feb 2016
  42. Delivered lecture as invited speaker - 47th Annual Conference of the Society of Nuclear Medicine, India, at JIPMER, Puducherry Feb 2016
  43. Delivered oral presentation - 12th Annual Conference of Indian Society of Bone Mineral Research, at Mumbai Sept-Oct 2016
  44. Poster presentation in 4th Theranostic World Congress 2016 at Melbourne, Australia Nov 2016
  45. Delivered lecture as invited speaker – National Symposium on Applications of Radioisotopes and Radiation Technology in Industry, Healthcare and Agriculture at Patiala Nov 2016
  46. Delivered lecture as invited speaker- World Congress of Cardiology Imaging and Clinical Cardiology (WCCICC-2017) at Mumbai Feb 2017
  47. Attended Research Methodology Workshop at GMCH, Chandigarh April 2017
  48. Attended BCLS and ACLS courses at GMCH, Chandigarh May 2017
  49. Delivered invited lecture at Warmth Technical Academy, Coimbatore Aug 2017
  50. Delivered invited lecture at 11th NCSI at SVIMS, Tirupati Oct 2017
  51. Delivered invited lecture CME PET/CT at SKIMS, Srinagar Oct 2017
  52. Delivered invited lecture 8th ISBMR at PGIMER, Chandgarh Nov 2017
  53. Delivered invited talk as symposia speaker AsAES 2018, New Delhi 2018
  54. Delivered invited lecture Nuclear Medicine Symposium, Rishikesh 2018
  55. Oral/poster presentation at SNMMI2018 Annual Meeting, Philadelphia 2018
  56. Participated as delegate/preconference workshop at ISTS 2018 Mumbai 2018
  57. Delivered invited lecture WCCICC 2019 at Mumbai Feb 2019
  58. Poster presentation at SNMMI2019 Annual Meeting, Anaheim, USA June 2019
  59. Poster presentation at ASNC 2019 Annual Session, Chicago, USA Sept 2019
  60. Delivered invited lecture at 51st SNMICON 2019 at Mumbai Dec 2019
  61. Delivered invited lecture at World Heart Failure Summit Oct 2020 (virtual)
  62. Delivered invited lecture at 72th Annual Conference of CSI at Ahmedabad Dec 2020 (virtual)
  63. Delivered invited lecture at Current and Future Landscape of Prostate Cancer Management Dec 2020 (virtual)
  64. Delivered invited lecture at EnSPIRE (Endocrine Society of India), Chandigarh 2021 (virtual)
  65. Delivered oral and poster presentations in 2022 SNMMI Mid-Winter and ACNM Annual Conference, Orlando, USA Feb 2022
  66. Delivered invited lecture in Parathyroid Clinical Updates, Hyderabad (virtual) March 2022
  67. Attended Theme Meeting on ‘Recent Developments in Radioisotopes and Radiopharmaceuticals’ (RDRR-2022) organized by BARC-BRNS, Mumbai March 2022
  68. Poster presentation at SNMMI2022 Annual Meeting, Vancouver, Canada June 2022
  69. Participated as faculty in Theranos Conclave - SNMI Northern Chapter New Delhi Sept 2022
  70. Participated as faculty in 18th ISBMR 2022 Chandigarh Sept 2022
  71. Participated as faculty in 2nd Workshop-CME on PET/CT guided interventions, PGIMER, Chandigarh Nov 2022
  72. Participated as faculty in CME - SNMI Northern Chapter Rohatak Feb 2023
  73. Participated as faculty in Annual Conference of SNMI Northern Chapter New Delhi April 2023
  74. Delivered oral and poster presentations in SNMMI 2023Annual Conference, Chicago, IL USA June 2023
  75. Chaired the session in 3rd Foundation Day CME of Surgical Gastroenterology, Chandigarh Aug 2023
  76. Poster presentation at KSMO 2023 Seoul, South Korea Sept 2023
  77. Participated as faculty for lecture & chairing the session in 3rd WCCCICC, Mumbai Oct 2023
  78. Delivered lecture in CME “Current Trends in Pediatric Nuclear Medicine” Chandigarh Oct 2023
  79. Participated as faculty to deliver lecture and chaired the session in 14th Biennial conference of Nuclear Cardiological Society of India - NCSICON 2023, Jaipur Nov 2023 
  80. Participated as faculty to deliver Brig SK Mazumdar oration, panel discussion and chaired the session in 55th SNMICON 2023 Jodhpur Nov 2023 
  81. Chaired the session in Radiopharmaceuticals: Chemistry to Precision Medicine, Chandigarh March 2024
  82. Chaired the session in 15th Annual National Conference of Indian Society of Neuro-Oncology (ISNOCON 2024), Chandigarh April 2024
  83. Participated as faculty to deliver lecture, panel discussion and chaired the session in CME “Advances in Functional Imaging & Theranostics in Oncology”, Rishikesh April 2024
  84. Chaired the session in 22nd Annual Conference of Association of Nuclear Medicine of India (ANMPI 2024), Chandigarh Sept 2024
  85. Chaired the session in EBSCON 2024 - Updates in Endocrine and Breast Surgery, Chandigarh Dec 2024 
  86.  Presented the poster in 2025 ASCO Annual Meeting, Chicago, USA, June 2025 
  87. Delivered lecture in CME “Updates on metastatic genito-urinary malignancies” Chandigarh May 2025
  88. Delivered lecture in 5th Foundation Day Surgical Videos Workshop & CME Chandigarh August 2025
  89. Participated as faculty in panel discussion World Head & Neck Cancer Week Head & Neck Cancer Forum, Amritsar August 2025
  90. Participated as faculty in panel discussion “15th Biennial Conference of Nuclear Cardiological Society of India NCSICON 2025” Faridabad March 2025
  91. Participated as faculty in panel discussion “Thyroid and Bone: Research, Practice and beyond” Chandigarh September 2025
  92. Chaired the session in EBSCON 2024 - Updates in Endocrine and Breast Surgery, Chandigarh Dec 2024 
  93. Delivered lecture in Nuclear Medicine-Northern Chapter: SNMI Annual Conference New Delhi April 2025
  94. Delivered lecture in Nuclear Medicine-Northern Chapter: SNMI Annual Conference New Delhi April 2025
  95. Delivered oral paper in Society of Nuclear Medicine & Molecular Imaging (SNMMI) Annual Meeting, New Orleans, Louisiana, USA, June 2025
  96. Participated as faculty to deliver lecture, and panel discussion in “4th Biennial World Congress on Cardiac Imaging and Clinical Cardiology-WCCICC 2025” Mumbai October 2025
  97. Delivered lecture in Nuclear Medicine-Northern Chapter: SNMI Annual Conference New Delhi June 2026
  98. Reviewer of National & International peer-reviewed journals related to subject including The Lancet and The Lancet Oncology

Referees:

  1. Prof. Rakesh Kumar,Head, Department of Nuclear Medicine,All India Institute of Medical SciencesNew Delhi-110029Email: rkphulia@yahoo.com